Heterologous cell–cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1)
Open Access
- 15 December 2003
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (12) , 2497-2509
- https://doi.org/10.1111/j.1538-7836.2003.00479.x
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- Neuroprotective Effect of SolCD39, a Novel Platelet Aggregation Inhibitor, on Transient Middle Cerebral Artery Occlusion in RatsStroke, 2003
- Inflammation in atherosclerosisNature, 2002
- Points of control in inflammationNature, 2002
- Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brainJournal of Clinical Investigation, 2002
- Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.Journal of Clinical Investigation, 1998
- Purification and Cloning of a Soluble ATP-Diphosphohydrolase (Apyrase) from Potato Tubers (Solanum tuberosum)Biochemical and Biophysical Research Communications, 1996
- Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins.Journal of Clinical Investigation, 1993
- Low density lipoprotein uptake by an endothelial-smooth muscle cell bilayerJournal of Vascular Surgery, 1991
- Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitroBiochemical and Biophysical Research Communications, 1982